Tekturna HCT FDA Approval History
FDA Approved: Yes (First approved January 18, 2008)
Brand name: Tekturna HCT
Generic name: aliskiren and hydrochlorothiazide
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure
Tekturna HCT (aliskiren and hydrochlorothiazide) is a single-tablet combination therapy for the treatment of high blood pressure.
Development Timeline for Tekturna HCT
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.